Skip to main content
SpringerLink
Log in

Immunology of Vaccine Adjuvants

  • Protocol
  • First Online:
Vaccine Adjuvants

Part of the book series: Methods in Molecular Biology ((MIMB,volume 626))

Abstract

In recent times vaccine adjuvants, or immunopotentiators, received abundant attention in the media as critical ingredients of current and future vaccines. Indeed, vaccine adjuvants are recognized to make the difference between competing vaccines based on identical antigens. Moreover, it is recognized that vaccines designed for certain indications require a matching combination of selected antigen(s) together with a critical immunopotentiator that selectively drives the required immune pathway with minimal adverse reactions. Recently, the mechanistic actions of some immunopotentiators have become clearer as a result of research focused on innate immunity receptors. These insights enable more rational adjuvant and vaccine design, which, ideally, is based on predictable immunophenotypes following vaccination.

This chapter addresses immunopotentiators, classed according to their (presumed) mechanisms of action. They are categorized functionally in two major groups as facilitators of signal 1 and/or signal 2. The mode(s) of action of some well-known adjuvant prototypes is discussed in the context of this classification.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Van Duin, D., Medzhitov, R., Shaw, A. C. (2006) Triggering TLR signalling in vaccination. Trends Immunol 27, 49–55.

    Article  PubMed  Google Scholar 

  2. Schijns, V. E. J. C. (2000) Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 12, 456–463.

    Article  PubMed  CAS  Google Scholar 

  3. Gershon, A. A. (2003) Varicella vaccine: rare serious problems-but the benefits still outweight the risks. J Infec Dis 7, 945–947.

    Article  Google Scholar 

  4. Rappuoli, R. (2007) Bridging the knowledge gaps in vaccine design. Nat Biotechnol 25, 1361–1366.

    Article  PubMed  CAS  Google Scholar 

  5. Schijns, V. E. J. C., Degen, W. G. J. (2007) Vaccine immunopotentiators of the future. Clin Pharm Therap 82, 750–755.

    Article  PubMed  CAS  Google Scholar 

  6. Guy, B. (2007) The perfect mix: recent progress in adjuvant research. Nat Microbiol 5, 505–517.

    Article  CAS  Google Scholar 

  7. Marciani, D. J. (2003) Vaccine adjuvants: role and mechanism of action in vaccine immunogenicity. Drugs Disc Today 8, 934–943.

    Article  CAS  Google Scholar 

  8. Schijns, V. E. J. C. (2001) Induction and direction of immune responses by vaccine adjuvants. Crit Rev Immunol 21, 75–85.

    Article  PubMed  CAS  Google Scholar 

  9. Janeway, C. A., Jr. (1989) Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol 54, 1–13.

    Article  PubMed  CAS  Google Scholar 

  10. Schijns, V. E. J. C., O’Hagan, D. (2006) Immunopotentiators in Modern Vaccines, Elsevier/Academic press, London.

    Google Scholar 

  11. Bretscher, P., Cohn, M. (1970) A theory of self-nonself discrimination. Science 169, 1042–1049.

    Article  PubMed  CAS  Google Scholar 

  12. Lafferty, K. J., Cunningham, A. J. (1975) A new analysis of allogenic interactions. Aust J Exp Biol Med Sci 53, 27–42.

    Article  PubMed  CAS  Google Scholar 

  13. Itano, A. A., McSorley, S. J., Reinhardt, R. L., Ehst, B. D., Ingulli, E., Rudensky, A. Y., Jenkins, M. K. (2003) Distinct dendritic cell populations sequentially present antigen to Cd4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19, 47–57.

    Article  PubMed  CAS  Google Scholar 

  14. Mackay, C. R. (1993) Homining of naïve memory and effector lymphocytes. Curr Opin Immunol 5, 423–427.

    Article  PubMed  CAS  Google Scholar 

  15. Butcher, E. C., Picker, L. J. (1996) Lymphocyte homing and homeostasis. Science 272, 60–66.

    Article  PubMed  CAS  Google Scholar 

  16. Zinkernagel, R. M., Ehl, S., Aichele, P., Oehen, S., Kundig, T., Hengartner, H. (1997) Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev 156, 199–209.

    Article  PubMed  CAS  Google Scholar 

  17. Freund, J. (1951) The effect of paraffin oil and mycobacteria on antibody formation and sensitization. Am J Clin Pathol 21, 645–656.

    PubMed  CAS  Google Scholar 

  18. Karrer, U., Althage, A., Odermatt, B., Roberts, C. W. M., Korsmeyer, S. J., Miyawaki, S., Hengartner, H., Zinkernagel, R. M. (1997) On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11 –/– ) mutant mice. J Exp Med 185, 2157–2170.

    Article  PubMed  CAS  Google Scholar 

  19. Frey, J. R., Wenk, P. (1957) Experimental studies on the pathogenesis of contact eczema in the guinea pig. Int Arch Allergy 11, 81–100.

    Article  PubMed  CAS  Google Scholar 

  20. Barker, C. F., Billingham, R. E. (1967) The role of regional lymphatics in the skin homograft response. Transplantation 5, 962–975.

    Article  PubMed  Google Scholar 

  21. Lascelles, A. K., Eagleson, G., Beh, K. J., Watson, D. L. (1989) Significance of Freund’s adjuvant/antigen injection granuloma in the maintenance of serum antibody response. Vet Immunol Immunopathol 22, 15–27.

    Article  PubMed  CAS  Google Scholar 

  22. Banchereau, J., Steinman, R. M. (1989) Dendritic cells and the control of immunity. Nature 392, 245–252.

    Article  Google Scholar 

  23. Herbert, W. J. (1966) Antigenicity of soluble protein in the presence of high levels of antibody: a possible mode of action of the antigen adjuvants. Nature 210, 747–748.

    Article  PubMed  CAS  Google Scholar 

  24. Herbert, W. J. (1968) The mode of action of mineral-oil emulsion adjuvants on antibody production in mice. Immunology 14, 301–318.

    PubMed  CAS  Google Scholar 

  25. Freund, J., Cascals, J., Hosmer, E. P. (1937) Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil. Proc Soc Exp Biol Med 37, 509–513.

    CAS  Google Scholar 

  26. Dupuis, M., Murphy, T. J., Higgins, D., Ugozzoli, M., van Nest, G., Ott, G., McDonald, D. M. (1998) Dendritic cells internalize vaccine adjuvant after intramuscular injection. Cell Immunol 186, 18–27.

    Article  PubMed  CAS  Google Scholar 

  27. Seubert, A., Monaci, E., Pizza, M., O‘Hagan, D. T., Wack, A. (2008) The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J Immunol 80, 5402–5412.

    Google Scholar 

  28. Ramanathan, V. D., Badenoch-Jones, P., Turk, J. L. (1979) Complement activation by aluminium and zirconium compounds. Immunology 37, 881–888.

    PubMed  CAS  Google Scholar 

  29. White, R. G., Coons, A. H., Connolly, J. M. (1955) Studies on antibody production. III. The alum granuloma. J Exp Med 102, 73–82.

    Article  PubMed  CAS  Google Scholar 

  30. Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Jr., Sutterwala, F. S., Flavell, R. A. (2008) Crucial role for the NAlp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453, 1122–1126.

    Article  PubMed  CAS  Google Scholar 

  31. Mckee, A. S., MacLeod, M., White, J., Crwaford, F., Kappler, J. W., Marrack, P. (2008) Gr1+IL-4-producing innate immune cells are induced in response to Th2 stimuli and suppress Th1-dependent antibody production. Int Immunol 20, 659–669.

    Article  PubMed  CAS  Google Scholar 

  32. Sun, H., Pollock, K. G., Brewer, J. M. (2003) Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine 21, 849–855.

    Article  PubMed  CAS  Google Scholar 

  33. Kool, M., Soullie, T., Nimwegen van, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., Lambrecht, B. N. (2008) Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med 205, 869–982.

    Article  PubMed  CAS  Google Scholar 

  34. Shi, Y., Evans, J. E., Rock, K. L. (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516–521.

    Article  PubMed  CAS  Google Scholar 

  35. Li, H., Nookala, S., Re, F. (2007) Aluminium hydroxide adjuvants activate caspase-1 and induce IL-1β and IL-18 release. J Immunol 178, 5271–5276.

    PubMed  CAS  Google Scholar 

  36. Sokolovska, A., Hem, S. L., HogenEsch, H. (2007) Activation of dendritic cells and induction of CD4+ T cell differentiation by aluminium-containing adjuvants. Vaccine 25, 4575–4585.

    Article  PubMed  CAS  Google Scholar 

  37. Franchi, L., Nunez, G. (2008) The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated Il-1β secretion but dispensable for adjuvant activity. Eur J Immunol 38, 2085–2089.

    Article  PubMed  CAS  Google Scholar 

  38. Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., Nemanzee, D. (2006) Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling. Science 314, 1936–1938.

    Article  PubMed  CAS  Google Scholar 

  39. Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., Akira, S. (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9, 143–150.

    Article  PubMed  CAS  Google Scholar 

  40. Pollock, K. G., Conacher, M., We, X. Q., Alexander, J., Brewer, J. M. (2003) Interleukin-18 plays a role in both the alum-induced T helper 2 response and the T helper 1 response induced by alum-adsorbed interleukin-12. Immunology 108, 137–143.

    Article  PubMed  CAS  Google Scholar 

  41. Schmitz, N., Kurrer, M., Kopf, M. (2003) The IL-1receptor 1 is critical for Th2 cell type airway immune response in a mild but not a more severe asthma model. Eur J Immunol 33, 991–1000.

    Article  PubMed  CAS  Google Scholar 

  42. McGuinness, D. H., Dehal, P. P., Pleass, R. J. (2003) Pattern recognition molecules and innate immunity to parasites. Trends Parasitol 19, 312–319.

    Article  PubMed  CAS  Google Scholar 

  43. Trinchieri, G., Sher, A. (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7, 179–190.

    Article  PubMed  CAS  Google Scholar 

  44. Blander, J. M., Medzhitov, R. (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440, 808–812.

    Article  PubMed  CAS  Google Scholar 

  45. Agrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, J., Van Dyke, T., Pulendran, B. (2003) Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct TH responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171, 4984–4989.

    PubMed  CAS  Google Scholar 

  46. Sutmuller, R. P. M., Morgan, M. E., Netea, M. G., Grauer, O., Adema, G. J. (2006) Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol 27, 387–393.

    Article  PubMed  CAS  Google Scholar 

  47. Malherbe, L., Mark, L., Fazileau, N., McHeyzer-Williams, L. J., McHeyzer-Williams, M. G. (2008) Vaccine adjuvants alter TCR-based selection thresholds. Immunity 28, 698–709.

    Article  PubMed  CAS  Google Scholar 

  48. Matzinger, P. (1994) Tolerance, danger and the extended family. Ann Rev Immunol 12, 991–1045.

    Article  CAS  Google Scholar 

  49. Ridge, J. P., Fuchs, E. J., Matzinger, P. (1996) Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271, 1723–1726.

    Article  PubMed  CAS  Google Scholar 

  50. Gallucci, S., Lolkema, M., Matzinger, P. (1999) Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5, 1249–1255.

    Article  PubMed  CAS  Google Scholar 

  51. Li, H., Willingham, S. B., Ting, J. P. -Y., Re, F. (2008) Inflammasome activation by alum and alum’s adjuvant effect are mediated by NLRP3. J Immunol 181, 17–21.

    PubMed  CAS  Google Scholar 

  52. Jegerlehner, A., Maurer, P., Bessa, J., Hinton, H. J., Kopf, M., Bachmann, M. F. (2007) TLR9 signaling in B cells determines class switch recombination to IgG2a. J Immunol 178, 2415–2420.

    PubMed  CAS  Google Scholar 

  53. Taylor, C. E. (1995) Cytokines as adjuvants for vaccines: antigen-specific responses differ from polyclonal responses. Infect Immunity 63, 3241–3244.

    CAS  Google Scholar 

  54. Soler, E., Houdebine, L.-M. (2007) Preparation of recombinant vaccines. Biotechnol Ann Rev 13, 65–93.

    Article  CAS  Google Scholar 

  55. Proietti, E., Bracci, L., Puzelli, S., Di Pucchio, T., Sestili, P., De Vincenzi, E., Venditti, M., Capone, I., Seif, I., De Maeyer, E., Tough, D., Donatelli, I., Belardelli, F. (2002) Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model. J Immunol 169, 375–383.

    PubMed  CAS  Google Scholar 

  56. Hatzifoti, C., Bacon, A., Marriott, H., Laing, P., Heath, A. W. (2008) Liposomal co-entrapment of CD40mAb induces enhanced IgG responses against bacterial polysaccharide and protein. PLoS ONE 3, e2368.

    Article  PubMed  Google Scholar 

  57. Kusuhara, K., Madsen, K., Jensen, L., Hellsten, Y., Pilegaard, H. (2007) Calcium signaling in regulating PGC-1a, PDK4 and HKII mRNA expression. Biol Chem 388, 481–485.

    Article  PubMed  CAS  Google Scholar 

  58. Netea, M. G., Sutmuller, R., Hermann, C., Van der Graaf, C. A., Van der Meer, J. W., van Krieken, J. H., Hartung, T., Adema, G., Kullberg, B. J. (2004) Toll-like receptor 1 suppresses immunity against Candida albicans through induction of IL10 and regulatory T cells. J Immunol 172, 3712–3718.

    PubMed  CAS  Google Scholar 

  59. Jarnicki, A. G., Conroy, H., Brereton, C., Donnelly, G., Toomey, D., Walsh, K., Sweeney, C., Leavy, O., Fletcher, J., Lavelle, E. C., Dunne, P., Mills, K. H. (2008) Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics. J Immunol 180, 3797–3806.

    PubMed  CAS  Google Scholar 

  60. Pedersen, A. E., Ronchese, F. (2007) CTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansion. J Immune Based Ther Vaccines 5, 9–15.

    Article  PubMed  Google Scholar 

  61. Sutmuller, R. P., van Duivenvoorde, L. M., van Elsas, A., Schumacher, T. N., Wildenberg, M. E., Allison, J. P., Toes, R. E., Offringa, R., Melief, C. J. (2001) Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 194, 823–832.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cell Biology & Immunology, Wageningen University, Wageningen, The Netherlands

    Carla M.S. Ribeiro & Virgil E.J.C. Schijns

Authors
  1. Carla M.S. Ribeiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Virgil E.J.C. Schijns
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Virgil E.J.C. Schijns .

Editor information

Editors and Affiliations

  1. Dept. Cardio & Vascular Sciences, St. George's University of London, Cranmer Terrace, London, SW17 0RE, United Kingdom

    Gwyn Davies

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Ribeiro, C.M., Schijns, V.E. (2010). Immunology of Vaccine Adjuvants. In: Davies, G. (eds) Vaccine Adjuvants. Methods in Molecular Biology, vol 626. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-585-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-585-9_1

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-584-2

  • Online ISBN: 978-1-60761-585-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation